Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details

v2.4.0.8
Balance Sheet Details
9 Months Ended
Sep. 30, 2013
Supplemental Balance Sheet Disclosures [Abstract]  
Balance Sheet Details
4. Balance Sheet Details
Cash and cash equivalents and investments consist of the following:
 
September 30,
2013
 
December 31,
2012
Cash and cash equivalents
$
26,500

 
$
21,810

Short-term investments
35,975

 
50,265

Long-term investments
20,544

 
5,181

 
$
83,019

 
$
77,256


Inventory consists of the following:
 
September 30,
2013
 
December 31,
2012
Work-in-process
$
3,410

 
$
3,233

Finished goods
6,265

 
6,658

 
$
9,675

 
$
9,891


Property and equipment consist of the following:
 
Useful Life
(in Years)
 
September 30,
2013
 
December 31,
2012
Furniture and fixtures
5
 
$
346

 
$
355

Machinery and equipment
3 -5
 
9,216

 
8,331

Masks and production equipment(1)
2
 
4,756

 
4,894

Software
3
 
728

 
736

Leasehold improvements
4 -5
 
854

 
829

Construction in progress
N/A
 
111

 
20

 
 
 
16,011

 
15,165

Less accumulated depreciation and amortization
 
 
(10,121
)
 
(8,299
)
 
 
 
$
5,890

 
$
6,866

(1)In the nine months ended September 30, 2013, the Company recorded an impairment charge of $1.1 million, reflected in cost of net revenue, related to the remaining net book value of production masks that were previously capitalized, but for which future use is no longer expected.
Intangible assets consist of the following:
 
Weighted
Average
Amortization
Period
(in Years)
 
September 30,
2013
 
December 31,
2012
Licensed technology
3
 
$
2,821

 
$
1,865

Less accumulated amortization
 
 
(1,992
)
 
(1,590
)
 
 
 
$
829

 
$
275


The following table presents future amortization of the Company’s intangible assets at September 30, 2013:
 
Amortization
2013
$
79

2014
319

2015
319

2016
112

Total
$
829


Deferred revenue and deferred profit consist of the following:
 
September 30,
2013
 
December 31,
2012
Deferred revenue—rebates
$
72

 
$
23

Deferred revenue—distributor transactions
4,678

 
3,735

Deferred cost of net revenue—distributor transactions
(1,703
)
 
(1,469
)
 
$
3,047

 
$
2,289


Accrued price protection liability consists of the following activity:
 
Nine Months Ended
September 30,
 
2013
 
2012
Beginning balance
$
7,880

 
$
2,856

Charged as a reduction of revenue
15,920

 
9,406

Reversal of unclaimed rebates
(27
)
 

Payments
(11,276
)
 
(4,311
)
Ending Balance
$
12,497

 
$
7,951


Accrued expenses and other current liabilities consist of the following:
 
September 30,
2013
 
December 31,
2012
Accrued technology license payments
$
3,000

 
$
2,996

Accrued professional fees
285

 
386

Accrued litigation costs(1)
1,812

 
586

Other
992

 
1,055

 
$
6,089

 
$
5,023


(1)Includes a one-time payment of $1.25 million to Silicon Labs in connection with the settlement agreement which is reflected in selling, general and administrative expenses in the three and nine months ended September 30, 2013.